Munich, Germany

Daniel Wilmes

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Brainlab Ag. Active years: 2025.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Daniel Wilmes in Mixed Reality Technology

Introduction

Daniel Wilmes is an innovative inventor based in Munich, Germany. He has made significant contributions to the field of mixed reality technology, particularly in medical environments. His work focuses on enhancing the usability and perceptibility of virtual objects displayed through mixed reality glasses.

Latest Patents

Wilmes holds a patent for a method titled "Local dimming of mixed reality glasses in medical environment." This patent describes a technique for performing local dimming within a display area of mixed reality glasses. The method aims to improve the visibility of virtual objects while minimizing the obstruction of real-world objects. By reducing the dimming intensity in specific areas, Wilmes' invention enhances the overall user experience in medical applications.

Career Highlights

Daniel Wilmes is currently employed at Brainlab AG, a company known for its innovative solutions in the medical technology sector. His work at Brainlab AG has allowed him to collaborate with talented professionals in the field, further advancing the development of mixed reality applications.

Collaborations

Some of Wilmes' notable coworkers include Laura Kern and Julia Doerner. Their collaborative efforts contribute to the ongoing advancements in mixed reality technology and its applications in healthcare.

Conclusion

Daniel Wilmes is a pioneering inventor whose work in mixed reality technology is shaping the future of medical environments. His innovative patent demonstrates a commitment to improving user experience and enhancing the visibility of virtual objects.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…